Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 19Neoplasm Metastasis 2Prostatic Neoplasms, Castration-Resistant 1Prostate Adenocarcinoma 1Pain 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-resistant Prostate Cancer 1Fatigue 1Castration-resistant Prostate Cancer 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Biochemical Recurrent Prostate Cancer 1

Interventions

Fentanyl 27Analgesia 23Morphine 20Acupuncture Therapy 18Surveys and Questionnaires 16Oxycodone 16Zoledronic Acid 15Acetaminophen 14Therapeutics 13Radiotherapy 13Psychiatric Rehabilitation 13Ketamine 13Methadone 11Lidocaine 11Hydromorphone 11Bupivacaine 11nabiximols 10Ibandronic Acid 10Ropivacaine 9Early Intervention, Educational 7Analgesics, Opioid 7Saline Solution 6Music Therapy 6Cryotherapy 6Cryosurgery 6Yoga 5Water 5Tapentadol 5Pregabalin 5Methods 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × Radium-223 × Clear all
NCT02278055 2023-04-07

Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
29 enrolled 10 charts
Genitourinary

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡